Abera Bioscience AB (NGM:ABERA)
Sweden
· Delayed Price · Currency is SEK 7.50
-0.30 (-3.85%)
At close: Aug 8, 2025
Abera Bioscience AB Revenue
Abera Bioscience AB had revenue of 3.57M SEK in the quarter ending March 31, 2025, with 57.44% growth. This brings the company's revenue in the last twelve months to 15.93M, up 232.42% year-over-year. In the year 2024, Abera Bioscience AB had annual revenue of 14.63M with 479.60% growth.
Revenue (ttm)
15.93M
Revenue Growth
+232.42%
P/S Ratio
6.99
Revenue / Employee
3.19M
Employees
5
Market Cap
111.30M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Investor AB | 85.17B |
| Atlas Copco AB | 173.03B |
| AB Volvo | 500.08B |
| EQT AB | 30.08B |
| ASSA ABLOY AB | 152.95B |
| Skandinaviska Enskilda Banken AB | 78.55B |
| Swedbank AB | 72.19B |
| Sandvik AB | 121.46B |